Summary
- Current Price
- As of today, SUPN price is $48.27, up +2.38% on
- Current Price All-Time High
- SUPN price is currently -21.19% below its historical high of $61.25 set on
- Market Cap
- SUPN current market cap is $3B, up +18.64% over the past 365 days
- Revenue
- SUPN current annual revenue is $718.95M, up +8.63% year-over-year
- Next Earnings
- The next earnings release for SUPN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Supernus Pharmaceuticals, Inc. |
| Ticker | NASDAQ: SUPN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | supernus.com |
| Employees | 674 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $48.27 | |
| Price, 1D Change | +2.38% | |
| $3B | ||
| - | ||
| - | ||
| 0.47 | ||
| $718.95M | ||
| Revenue, 1Y Change | +8.63% | |
| -$0.68 | ||
| EPS, 1Y Change | -151.73% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.68 | ||
| EPS Estimate | $2.57 | N/A |
| EPS Est. Change | +475.60% | N/A |
| $718.95M | ||
| Revenue Estimate | $885.80M | N/A |
| Revenue Est. Change | +23.21% | N/A |
| Current Price | $48.27 | |
| Price Target | $62.50 | - |
| Price Tgt. Change | +29.48% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.87 | $1.32 | -54.06% | |
| $2.63 | -$0.68 | -126.02% | |
| $2.57 | N/A | +475.60% | |
| $4.46 | N/A | +753.10% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $642.90M | $661.82M | +2.94% | |
| $702.52M | $718.95M | +2.34% | |
| $885.80M | N/A | +23.21% | |
| $1.37B | N/A | +90.78% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $48.27 | |
| $48.82 | ||
| $46.43 | ||
| $47.01 | ||
| $47.09 | ||
| $0.23 | ||
| 0.47 | ||
| $2.01 | ||
| 55.25 | ||
| 59.26% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $718.95M | ||
| -$0.68 | ||
| $644.39M | ||
| 89.63% | ||
| -$36.86M | ||
| -5.13% | ||
| -$38.55M | ||
| -5.36% | ||
| $44.40M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.04 | ||
| 1.90 | ||
| 1.66 | ||
| - | ||
| 3 | ||
| 4.10 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 3.38 | ||
| 2.72 | ||
| 65.98 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $1.06B | ||
| $308.67M | ||
| $1.61B | ||
| $644.18M | ||
| $552.44M | ||
| $338.17M | ||
| $40.98M | ||
| $10.61M | ||
| $2.68M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $757.50M | ||
| $681.25M | ||
| $166.13M | ||
| $0.00 | ||
| $91.56M | ||
| $0.00 | ||
| -$10.48M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $47.33M | ||
| $4.11M | ||
| $9.13M | ||
| $1.34M | ||
| $45.99M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Cantor Fitzgerald | → | |
| Stifel | → | |
| B of A Securities | ||
| TD Cowen | → | |
| Piper Sandler | → | |
| Cantor Fitzgerald | → | |
| Piper Sandler | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → |
Analyst sentiment
Institutional ownership
No data
Screeners with SUPN
FAQ
- What is the ticker symbol for Supernus Pharmaceuticals, Inc.?
- The ticker symbol for Supernus Pharmaceuticals, Inc. is NASDAQ:SUPN
- Does Supernus Pharmaceuticals, Inc. pay dividends?
- No, Supernus Pharmaceuticals, Inc. does not pay dividends
- What sector is Supernus Pharmaceuticals, Inc. in?
- Supernus Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is Supernus Pharmaceuticals, Inc. in?
- Supernus Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Supernus Pharmaceuticals, Inc. based in?
- Supernus Pharmaceuticals, Inc. is headquartered in United States
- When did Supernus Pharmaceuticals, Inc. go public?
- Supernus Pharmaceuticals, Inc. initial public offering (IPO) was on May 1, 2012
- Is Supernus Pharmaceuticals, Inc. in the S&P 500?
- No, Supernus Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is Supernus Pharmaceuticals, Inc. in the NASDAQ 100?
- No, Supernus Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is Supernus Pharmaceuticals, Inc. in the Dow Jones?
- No, Supernus Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was Supernus Pharmaceuticals, Inc. last earnings report?
- Supernus Pharmaceuticals, Inc.'s most recent earnings report was on August 3, 2026
- When does Supernus Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for Supernus Pharmaceuticals, Inc. is November 3, 2026
Data Sources & References
- SUPN Official Website www.supernus.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1356576/000135657626000011/0001356576-26-000011-index.htm
- SUPN Profile on Yahoo Finance finance.yahoo.com/quote/SUPN
- SUPN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/supn